Abstract:<p>Leakage and compression of blood vessels may result in deprivation of blood flow to a large number of tumor tissues, which can lead to tumor hypoxia. Hypoxia induces an increase in the expression of hypoxia-inducible factor 1 in tumor cells, which induces angiogenesis in tumors through the high expression of vascular endothelial growth factor, thereby forming a positive feedback vicious circle. Improving hypoxia by normalizing blood vessels and improving radiosensitivity by immunotherapy has emerged as a new application of combined immunotherapy and radiotherapy. Interferon γ produced by CD4 + /CD8 + T cells, induced by immune checkpoint inhibitors, plays an important role in the normalization of blood vessels; tumor-associated eosinophils also play a role in the process of immunotherapy-induced blood vessel normalization. In addition, the reduction in regulatory T cells induced by immune checkpoint inhibitors can increase eosinophil levels, which promotes the further development of vascular normalization mechanisms. This review focuses on the mechanism of immunotherapy to normalize blood vessels, and proposes a good prospect for improving hypoxia. Due to the narrow vascular normalization window of anti-angiogenesis therapy, discovery of the vascular normalization effect of immunotherapy provides a new idea for the combined application of immunotherapy and radiotherapy. The enlarged vascular normalization window and improved hypoxia provide a good opportunity for the subsequent implementation of radiotherapy. The above sorting and analysis may pave the way for a promising strategy for cancer treatment via combined immunotherapy and radiotherapy.</p>

Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy.

Tumor Vessel Normalization: A Window to Enhancing Cancer Immunotherapy

[Vascular Normalization and Cancer Immunotherapy].

Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy

Tumor vascular normalization improves cancer treatment efifcacy

Anti-angiogenic Therapy for Tumor: Tumor Angiogenesis, Vasculogenic Mimicry and Vascular Normalization

Study of Tumor Microenvironment to Vascular Normalization Based on 3-D Simulation of Tumor Haemodynamics

Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization

Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy

Anti-angiogenic Nano-Delivery System Promotes Tumor Vascular Normalizing and Micro-Environment Reprogramming in Solid Tumor

Antiangiogenic Therapy Improves the Antitumor Effect of Adoptive Cell Immunotherapy by Normalizing Tumor Vasculature

Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade

Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment

[Study on the Tumor Microenvironment and Tumor Vascular Normalization in Integrative Treatment of Tumor by Chinese Medicine and Western Medicine].

Inducing Vascular Normalization: A Promising Strategy for Immunotherapy.

Research on the Effect of Microenvironment of Tumor Blood Perfusion under Anti-angiogenesis Therapy

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy

Normalization of tumor vasculature: A potential strategy to increase the efficiency of immune checkpoint blockades in cancers

Study of Tumor Blood Perfusion and Its Variation Due to Vascular Normalization by Anti-Angiogenic Therapy Based on 3D Angiogenic Microvasculature